How to Choose a Psychedelic Therapy Provider
- Many people seek psychedelic therapy when traditional treatments do not work, or to achieve a higher state of consciousness that’s believed to facilitate deeper healing.
- The legality of psychedelic treatment is still developing. In Europe, Switzerland, Germany, and the Czech Republic have frameworks for medical psychedelic treatment. Other providers such as outpatient clinics and retreats offer psychedelic therapy in legal grey areas.
- When trying to find a psychedelic provider, research, credentials, pricing, and duration are essential considerations. The first consultation should be an honest exchange between you and the provider to check there’s a genuine fit.
- Provider red flags include overpromising, being pushy, lack of preparation and integration work, inexperience with psychedelics, and no in-depth screening process.
Half of people who receive psychiatric treatments do not respond1 to treatments currently available. It’s no surprise then, curiosity around psychedelic therapies, practices, and offerings has grown substantially2 in recent years in Europe. As demand grows, there’s a greater need for clear information about finding a psychedelic provider.
The commercial psychedelic space is new and standardised regulation is still being implemented. Knowing how to even start the search for a provider can feel overwhelming, let alone the process of vetting practitioners, and choosing one that is safe and acutely aligns with your needs.
If you’re looking for a psychedelic provider, chances are you’ve already explored other options and are maybe disillusioned with the systems that are supposed to look after your health. Or, you may simply be interested in alternative medicines. Either way, this guide is for you: to navigate choosing a psychedelic provider in the most secure, straightforward, and successful way — with advice from psychedelic experts and providers themselves.
What is Psychedelic Therapy?
Psychedelic therapy, sometimes called ‘psychedelic-assisted therapy’, is when psychedelic substances are used to guide mental or physical healing. The substances used change your perception, mood, and cognitive function. Some of the most commonly used psychedelics for therapeutic work are MDMA, ketamine, ibogaine, and psilocybin.
Psychedelic therapy can be sought for a wide variety of conditions, but it’s predominantly used for anxiety, depression, PTSD, and chronic pain after other treatment options have been tried. It’s administered in a controlled environment by specialists, and requires preparatory and integrative work before and after sessions.
The basis for psychedelic therapy is that it allows you to reach a higher state of consciousness, where you can access emotions, memories, and pathways that facilitate more profound healing. Many psychedelics also promote neuroplasticity in the brain, which is proven to reduce mental health symptoms common in depression and anxiety. And, research shows that psychedelic-assisted therapy can contribute to remission rates of up to 85%3.
Not only are these outcomes significant, they position psychedelic therapy as a genuine treatment option for people with conditions that have a high probability of not responding to first-line care.
What exactly psychedelic therapy looks like depends on the psychedelic you choose, the condition you’re treating, and your unique health requirements. For example, psilocybin therapy won’t have the same preparatory work, time commitment, and integrative requirements as ayahuasca.
Psychedelic therapy is not new: it was pioneered in the 1950s4 to treat mood disorders and substance use disorders. After laws restricted research, it resurged in the 1990s and continues to be studied to this day. Because it’s considered a novel and innovative treatment, the legality of psychedelic treatment is still developing. Currently, in Europe, frameworks for medical access to psychedelic treatment exist in Switzerland, Germany, and the Czech Republic. However, there are centres across the continent that operate in legal grey areas and safely offer psychedelic therapy.
What Types of Psychedelic Providers Are There?
Psychedelic providers typically fall into three categories: registered medical programs, outpatient clinics, and retreats. Keep in mind that because legislation for psychedelic therapy is ongoing, these categories are not fixed definitions of all the treatments available in Europe.
Registered Medical Programs
These include programs in Switzerland, where doctors are authorised to use LSD, psilocybin, and MDMA with special medical approval. They also encompass countries that allow compassionate use for psychedelics, such as psychedelic research programs in hospitals for treatment-resistant conditions in Germany and Canada.
Any academic hospital or research site that runs regulated trials for psychedelic treatments is considered a registered medical program.
Outpatient Clinics
Outpatient care has different parameters compared to hospital care that can make psychedelic therapy legal (and semi-legal) in clinics. For example, in the UK and Czech Republic, private clinics offer ketamine therapy off-label for psychiatric conditions. Similarly, licensed therapists working in independent practices may recommend psychedelic therapy as part of patients’ broader care plan, without themselves administering psychedelics.
Retreats
Retreats are privately owned and run spaces that offer psychedelic therapy. In the Netherlands, psilocybin truffle retreats operate through a legal loophole after the government banned magic mushrooms in 2008.
Providers may also host retreats with psychedelic medicines that come from ancestral traditions, such as ayahuasca or iboga, both of which originate in Indigenous communities. In Spain and Portugal, ancestral psychedelic retreats fall into a grey legal area.
Microdosing
Microdosing is when a person takes a very small amount of a psychedelic on a regular basis. This practice isn’t intended to cause a high sensation, but to improve daily mood and productivity, and to help treat health conditions very gradually. In Europe, there’s no legal framework that governs microdosing, meaning it’s not available as part of structured care. However, many people microdose independently or with a psychedelic guide.
First Steps to Find a Psychedelic Provider
Many people start their search with a simple Google query, which can be productive, but can miss some of the important nuances that help match you with the right psychedelic provider. Psychedelic therapy practitioners can help uncover some of those nuances. We asked a variety of experts with real experience in the psychedelic world how to make the search safe and in-depth.
Joel Brierre, founder and CEO of Kaivalya Ventures Inc., an ecosystem for 5-MeO-DMT, recommends first researching the psychedelic you’re interested in. He says to then Google it and pay attention to verified third-party reviews (not just testimonials on social media).
Laura Shapiro, Founder and CEO of Bassé, an ibogaine treatment clinic for addiction and trauma, suggests going further than a digital presence. She says speaking with people in therapeutic and psychedelic communities can lead to referrals to providers and centers with an established reputation.
Meanwhile, Kat Courtney, a plant medicine facilitator and founder of Plant Medicine People, and Dori Lewis, a licensed natural medicine consultant and co-founder of Elemental Psychedelics, emphasise reading about the psychedelic space. Kat explains that watching videos about different providers can help you understand what to expect. Dori adds that looking up terminology from the psychedelic world can give you language to bring to your first consultation.
The most important conversations shaping the future of psychedelics, delivered weekly.
From thought-provoking podcasts and original stories to research breakthroughs and industry news, stay connected to the conversations that matter.
Joined by 12,000+ readers
What Should I Ask at a First Consultation?
A first consultation not only influences your relationship with the provider, but also the psychedelic experience itself. The questions you ask at this moment give you a transparent idea of who the provider is, their values, how they conduct themselves and the practice, and whether they fit with your therapy goals.
According to psychedelic experts, questions to ask include:
- What training does the provider have? When was the training completed?
- How many people has the provider worked with? What have the outcomes been?
- What steps do they take to make the therapy physically, emotionally, and spiritually safe?
- How do they support preparation and integration before and after the therapy?
- What are some of the hardest experiences they’ve had with psychedelics and how did they move through it?
- What support is available during the therapy? What is the emergency protocol?
- Is the therapy trauma-informed? How, and for what types of trauma?
- How long does the therapy last? When can it start?
- Is there anyone they do not recommend for the therapy? If they are offering a medicine that comes from an indigenous lineage, do they have permission and training from that community?
Laura and Dori equally stress that the first consultation is when you should be completely honest with the provider: disclosing your medical and psychiatric history, as well as if you have been involved in any traumatic events. Accurate information means the provider can properly assess if treatment is appropriate and safe for you. Additionally, the provider can share if they have specialists who work in the areas of support that you specifically need.
Psychedelic Provider Credentials
As of 2026, there is no standardised certification for psychedelic providers in Europe. That said, PsyStandard is a European framework that assesses safety and competence in psychedelic practice. Through the platform, the ethics, setting, and preparation and integration of psychedelic practices are verified. The initiative has been designed with academic institutions, harm reduction experts, and practitioner communities.
The very basic (non-negotiable) credentials a psychedelic provider needs are:
- A clinical license in mental health or medicine.
- Trained staff holding titles such as MD (Doctor of Medicine), DO (Doctor of Osteopathic Medicine), NP (Nurse Practitioner), and PhD (Doctor of Philosophy, which is not a medical qualification but demonstrates extensive research in medicine).
- Specialised training in psychedelic-assisted training: for example at MIND Foundation in Germany, Experiential Training Institute in the Netherlands, and Illuminismo Psichedelico Academy5 in Italy.
- A curriculum that operates within the legal requirements of the location of the provider.
- Safety guidelines, including emergency protocols — such as creating a safe environment to administer psychedelics, noting emergency contacts before the therapy, and having a de-escalation plan.
- Preparatory and integration strategies.
Psychedelicare has a list of dedicated resources that are useful to understand the psychedelic therapy landscape in Europe.
Red Flags to Be Aware Of
Like any decision surrounding your health and wellbeing, it’s essential to be aware of any indications that something’s off when choosing a psychedelic provider, especially because the provider will care for you when you’re in an altered state.
A big red flag is a provider who creates a sense of urgency around therapy, saying you need to undergo it immediately. The same applies to any provider that doesn’t offer preparatory work or sessions. If they encourage you to start treatment without prior learning, that’s both irresponsible and dangerous.
The same is true for integration. Joel says that even if a provider offers integration sessions after the therapy, the model can’t be “call us if you need”. Integration has to be a planned and intentional part of the experience, not an afterthought.
Laura adds that providers shouldn’t create a passive experience. You need to be willing to actively participate in your healing, she explains. And if a provider promises guaranteed results solely from the physiological effects of the therapy, that’s a red flag.
Other causes for concern include not having an in-depth screening before initiating the therapy. Providers have to take time to thoroughly assess your medical and psychological history, alongside your needs and treatment goals. They should not tell you to change your lifestyle or start/stop medications without consulting your doctor. Not having a meaningful screening may signal that the provider is only concerned with filling vacancies at the center.
For Indigenous and spiritual retreats, Kat highlights that providers should have medical and personal experience with the psychedelics they serve. They should know exactly what is in the therapies they administer, and they should have evidence for the training they have completed to be a trusted figure in the space (including formal Shamanic training from Indigenous communities).
How Long Does Psychedelic Therapy Last?
The duration of psychedelic-assisted therapy depends on the substance, the location, the program, the condition being treated, and other factors that are unique to you (e.g., your medical history and goals in therapy).
Psychedelic therapy is never a one-off event. No provider should offer a one-day dose as a miracle cure. The scope of therapy is broad, and you need to ask your (potential) provider how long sessions are and how long the total course is.
For example, each psilocybin session ranges between six and eight hours, and the course normally extends for several weeks. A single session for ketamine therapy, on the other hand, lasts around one hour, and requires around six sessions spread out across roughly four weeks.
Drinking ayahuasca happens during one session that lasts around six hours, usually overnight, but preparatory and integrative work happens weeks before and after the ceremony.
Price Considerations
There are also practical considerations in your psychedelic therapy search. Price is naturally a priority. Because psychedelic therapies are mostly private, the cost can be significant.
Each provider has its own fees and fee schedules that you should be able to easily access via their websites or by speaking to a representative.
A very general pricing framework for different types of psychedelic providers looks like:
- Psilocybin sessions in Switzerland range between 400 CHF (~€430) and 800 CHF (~€860) and, on average, are repeated three times a year.
- One session of LSD therapy in Switzerland typically costs 200-300 CHF (~€215-320). A complete psychedelic therapy program, with four sessions and integrated psychotherapy can cost several thousands.
- In the UK, ketamine treatment ranges between £300-800 (~€350-935) per single infusion. A six-session program over two to three weeks typically costs £2,400-6,800 (~€2,800-7,944).
- Legal psilocybin truffle retreats in the Netherlands charge roughly €400-600 for a two-day private session, €600-1,200 for a three-day group retreat, and €1,500+ for an extended five-day program.
- Three-seven day ayahuasca retreats in Spain or Portugal can cost €640-3,500.
- Ibogaine retreats in Portugal are in the thousands, and can reach up to €7,000.
For Kat, the amount you spend depends on the treatment you need, where it’s given, how long the course is, and the quality of care. She says that 1:1 work will cost more, while group therapies may be more affordable. Laura agrees, and says that the cost of psychedelic therapy is high because it includes continuous clinical oversight, preparation and integration, medical screening, and qualified professionals. She suggests that when you’re considering payment, ask yourself “what level of medical care, attention, and support will I receive for this price?”
At the same time, don’t be afraid to ask providers if they have payment plans, sliding scales, or referrals to other providers if the price is not accessible for you.
A Prepared Psychedelic Pathway
Choosing a psychedelic provider is a delicate process. It’s understandable to be in a hurry to access a new therapy or explore an altered state as part of your treatment, but rushing can create gaps in the pairing you land on.
It’s important to remember that psychedelic-assisted therapy is still a relatively new field, research is limited, treatments are highly regulated, and we still don’t fully understand the mechanisms of action, substances’ efficacy, risks, and much more. That’s precisely why psychedelics require strict due diligence.
As you start your search, ensure you absorb as much information about psychedelic therapy as possible. Read clinical studies, speak to medical professionals (in both the traditional and psychedelic world), contact people who have undergone psychedelic therapies, and always check in with yourself about your level of comfort and confidence as you move forward.
If you have questions, ask. If you have doubts, share. If you change your mind at any time, that’s perfectly fine. A psychedelic provider has to curate psychological safety — it’s a necessary foundation for the deeper work and healing that psychedelics open.
FAQ
Psychedelic therapy isn’t legal across Europe, but countries such as Switzerland and Germany allow controlled psychedelic treatment through special access programs and research trials. Other countries offer psychedelic therapy through legal grey areas, such as in the UK, where outpatient programs provide ketamine therapy off-label for psychiatric conditions.
It depends on the substance, the duration of the therapy, the location, and other unique factors. On average, individual psychedelic sessions can start from €400. Repeat sessions and weeks-long courses tend to cost thousands of euros.
Anyone with a mental health disorder such as schizophrenia or bipolar, or anyone who has suicidal behaviours. Similarly, anyone with a heart condition, a history of seizures, liver disease, or who is pregnant should not participate. Psychedelic providers should always ask during screening about medications you’re taking, to check for possible dangerous interactions.
It’s generally not recommended to engage with psychedelic therapy while taking antidepressants. Research is mixed around the potential harm of mixing psychedelics and antidepressants, but what is known is that antidepressants reduce the intensity6 of the therapeutic impact of substances such as psilocybin.
Ask a provider what training they have, where the training was completed, how many people they have worked with, what safeguarding they do, how they support preparation and integration, and what aftercare is available. Practical questions around how long the therapy lasts, and how much it costs are important, too.
A registered psychedelic medical program is government-regulated and usually takes place in a hospital. A psychedelic clinic exists in a legal grey area, but still follows standard medical guidelines. A retreat is independently run and typically takes place at a resort-like centre.
Generally speaking, no. Even for special access psychedelic programs in Switzerland, people have to pay out of pocket. However, Norway is the first country to publicly fund7 generic IV ketamine therapy for treatment-resistant depression.
